Orange Book product · Generic (ANDA)
ETHOSUXIMIDE
ETHOSUXIMIDE
At a glance
Mar 16, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 16, 2020
6 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
ETHOSUXIMIDE
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 210654
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETHOSUXIMIDE
- —ZARONTINBrand (NDA)
NDA 012380 · PARKE DAVIS
- 2019ETHOSUXIMIDEGeneric (ANDA)
ANDA 211928 · ONESOURCE SPECIALTY
- 2012ETHOSUXIMIDEGeneric (ANDA)
ANDA 200892 · HERITAGE PHARMS INC
- 2008ETHOSUXIMIDEGeneric (ANDA)
ANDA 040686 · EPIC PHARMA LLC
- 2003ETHOSUXIMIDEGeneric (ANDA)
ANDA 040506 · CHARTWELL RX
- 2002ETHOSUXIMIDEGeneric (ANDA)
ANDA 040430 · BIONPHARMA
- 2000ETHOSUXIMIDEGeneric (ANDA)
ANDA 040253 · PHARM ASSOC
- 1993ETHOSUXIMIDEGeneric (ANDA)
ANDA 081306 · TEVA PHARMS
- —ZARONTINGeneric (ANDA)
ANDA 080258 · PARKE-DAVIS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
